An update on advanced glycation endproducts and atherosclerosis.
about
The Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy AgingAssociation of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: A systematic review and meta-analysis.Optoacoustic detection of tissue glycation.The effect of chromium picolinate supplementation on the pancreas and macroangiopathy in type II diabetes mellitus rats.Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.Not all smokers die young: a model for hidden heterogeneity within the human populationAdvanced glycation end products and oxidative stress in type 2 diabetes mellitus.Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro.Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction.Skin Autofluorescence in Systemic Sclerosis Is Related to the Disease and Vascular Damage: A Cross-Sectional Analytic Study of Comparative GroupsUremic Toxicity of Advanced Glycation End Products in CKD.IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.AGEs, contributors to placental bed vascular changes leading to preeclampsia.A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases.Global Autorecognition and Activation of Complement by Mannan-Binding Lectin in a Mouse Model of Type 1 Diabetes.Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach.Redox homeostasis in stomach medium by foods: The Postprandial Oxidative Stress Index (POSI) for balancing nutrition and human health.Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.Prevention of age-induced N(ε)-(carboxymethyl)lysine accumulation in the microvasculature.Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents.Thermal stabilization of the deglycating enzyme Amadoriase I by rational design.AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.Susceptibility of adult and senescent Brown Norway rats to repeated ozone exposure: an assessment of behavior, serum biochemistry and cardiopulmonary function.Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease.Fossilization transforms vertebrate hard tissue proteins into N-heterocyclic polymersRole of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies
P2860
Q26771190-240AB530-CF98-482E-A6B3-26B9252AA5B6Q30240149-1F88C270-5DD3-45FB-8F1F-A51720D94C41Q30402345-AECB7420-BABA-4ADB-9184-5FD29B74A1A0Q33905136-C0DCE11A-1366-4378-87C7-EA86106189BAQ34072528-6476DB14-3C12-4754-B1CF-F2480749DF8FQ34350918-A4AA0D1E-5CD6-46E2-8432-1036055C3089Q35092632-9FC90AAB-E2D3-4274-9F62-BF65495741FDQ35255473-A4780FE0-0DBA-4FD8-BE82-40B80291B767Q35600704-D28302E6-A76E-4404-8445-A0D3DE5D711BQ35632399-E5E36A45-1B81-416B-95EA-123CB56DE1FFQ35924733-FD5E7EC4-6B67-4087-BF28-456601D7736AQ36514906-147019E9-12B6-4709-9EF8-503B009D9B38Q37305013-5F0BB0AB-0B5F-4626-8B98-C87178593062Q38116590-4D8A3740-3B22-4A1C-AF9C-92A4CB0AEF11Q38660995-DEA3ADF6-E251-465B-B15F-722020DDA010Q41038156-DA5DDBB2-7FDC-428D-8513-8C05DBC0E738Q41528907-78EB9678-DF62-4109-BDE5-04EE30F48491Q41777487-E37AA32E-6806-47B1-AEB0-4544AD1AB8AEQ46593878-7B539A1D-CF2C-47A9-B57E-4492A829D98BQ46611689-D80985CB-5CE7-4BF7-A467-DA0EFC2BC2D6Q48930767-617F5EFE-1CF2-42E2-92BE-1FD6877804E2Q49554778-3943A2CB-29ED-4C89-8466-AB2C096D54E8Q50326594-DF5403E2-70B1-411B-904E-A730CE8DC661Q51747235-24037C38-FD03-41A1-9299-C5CF1DB3A732Q53340449-F546DCF0-5C68-4A14-9631-C5180F399D99Q53646889-48DF99DA-5E72-49A3-96BD-3C00802C3083Q54434572-CFDB9CFF-98BE-4B7F-BC12-F7B1ABC457CBQ58568524-705D16E5-3331-4871-8E6D-E8A49ECF64C6Q58577346-A5BC1D4C-98CB-4C95-9D39-E5B0E244F75B
P2860
An update on advanced glycation endproducts and atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An update on advanced glycation endproducts and atherosclerosis.
@en
type
label
An update on advanced glycation endproducts and atherosclerosis.
@en
prefLabel
An update on advanced glycation endproducts and atherosclerosis.
@en
P2860
P356
P1433
P1476
An update on advanced glycation endproducts and atherosclerosis.
@en
P2860
P304
P356
10.1002/BIOF.1018
P577
2012-04-10T00:00:00Z